{"product_id":"bd-autoshield-duo-safety-pen-needle","title":"AutoShield Duo™ Pen Needles 5mm 30G 3bevel TW 100ct","description":"\u003cp\u003eAutoShield Duo™ is the only pen needle that passively covers the front and back needles, eliminating exposure after use.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStudies show that both ends of a pen needle are contaminated after use\u003csup\u003e1,2\u003c\/sup\u003e, so both ends of the needle require safety features\u003csup\u003e3\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003eColored shields on both the front and back-end needles provide visual and tactile confirmation of safety\u003c\/li\u003e\n\u003cli\u003eAutoShield Duo™ is the only pen needle that fits every diabetes pen\u003csup\u003e4\u003c\/sup\u003e, so you get the highest level of protection - no matter which pen you use\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eHere is a demo link on how it is used ---\u0026gt;\u003ca href=\"http:\/\/www.bdinteractivemedia.com\/AutoShield_IFU\/?product=duo\u0026amp;lang=en_us\u0026amp;reload=true\" target=\"_blank\"\u003ePlease note when you click on this link it will open a seperate window, outside of Diabetes Express\u003c\/a\u003e  \u0026lt;----\u003c\/p\u003e\n\u003cblockquote\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e1\u003c\/sup\u003e Kreugel G, Keers JC, Jongbloed A, Wolffenbuttel BHR. Randomized trial on the influence of the length of\u003cbr\u003etwo insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diab\u003cbr\u003eTech Ther 2011;13(7): DOI: 10.1089\/dia.2011.0010.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e2\u003c\/sup\u003e Kreugel G, Beijer HJM, Kerstens MN, Maaten ter JC, Sluiter WJ, Boot BS. Influence of needle size for subcutaneous insulin administration on metabolic control and patient acceptance. European Diabetes Nursing. 2007: Vol. 4 No. 2.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e3\u003c\/sup\u003e Kreugel G, Keers JC, Jongbloed A, et al. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes. 2009; 58(S1): 440.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e4\u003c\/sup\u003e Frid, A, et. al: New injection recommendations for patients with diabetes. Diabetes \u0026amp; Metabolism 2010;36: S3-S18.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e5\u003c\/sup\u003e OSHA Bloodborne Pathogen Standard: 29 CFR §1910.1030(c) (1)(iv), paragraphs (A) and (B).\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e6\u003c\/sup\u003e Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010; 26 (6): 1519–1530.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e7\u003c\/sup\u003e Karges B, Boehm BO, Karges W. Early hypoglycaemia after accidental intramuscular injection of insulin glargine. Diabet Med. 2005 Oct;22(10):1444-5.\u003c\/p\u003e\n\u003cp class=\"small-bullet-item\"\u003e\u003csup\u003e8\u003c\/sup\u003e Data on file at BD as of August 2011.\u003c\/p\u003e\n\u003c\/blockquote\u003e","brand":"embecta","offers":[{"title":"Default Title","offer_id":29239258514,"sku":"11640","price":59.54,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1579\/3465\/files\/329505_FCI89229_SAP04_vA_11_CENTER_30apr25-Photoroom.jpg?v=1772828282","url":"https:\/\/diebetesexpress.com\/products\/bd-autoshield-duo-safety-pen-needle","provider":"Diabetes Express","version":"1.0","type":"link"}